A post-treatment method for solid phase RNA synthesis and its application
By using ammonia methanol solution and a deprotectant compounded with N-methylpyrrolidone and triethylamine trihydrofolate in RNA post-treatment, the retention of DMT groups is achieved, and the difficulties of RNA degradation and purification are solved, and the simplification of simplification Operational procedures and reduce costs.
Patent Information
- Application Number
- CN202111048521.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-09-08
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2041-09-08
AI Technical Summary
The existing RNA post-treatment methods cannot retain DMT groups in the one-pot method, which makes RNA purification difficult, and the step-by-step operation is cumbersome, time-consuming, and costly, and the RNA is easy to degrade.
Ammonia methanol solution was used for ammonia decomposition, and N-methylpyrrolidone, triethylamine and triethylamine trihydrofolate were used as deprotection reagents to carry out a one-pot deprotection treatment, retaining DMT groups, and simplifying Operation to reduce RNA degradation.
It improves the purity and yield of RNA, simplifies the process flow, reduces costs, avoids the degradation of RNA, and is suitable for high-performance liquid chromatography purification.
Smart Images

Figure CN115772201B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology and relates to a post-processing method for solid-phase synthetic RNA and an application thereof. Background Art
[0002] At present, chemical synthesis of RNA is mostly based on solid phase synthesis technology. Solid phase synthesis uses controlled pore glass balls (CPG) as solid phase carriers, and four phosphoramidite monomers A, U, C and G (usually β-cyanoethyl phosphoramidite monomers whose 2' hydroxyl group is protected by tert-butyldimethoxysilyl (TBDMS)) as synthesis units. In the 3'-5' direction, the target sequence is gradually connected through a cycle of four reactions: deprotection, condensation, oxidation and capping (see: Andrew Ellington et al. Introduction to the Synthesis and Purification of Oligonucleotides, Current Protocols in Nucleic Acid Chemistry, 2001, A.3C.1-A.3C.22.), and then through a two-step reaction of one step of aminolysis and one step of TBDMS removal, the RNA's own protective group is removed, and after purification, the final RNA can be obtained.
[0003] During RNA synthesis, a dimethoxytrityl (DMT) group can be retained at its 5' end. This group has a higher lipophilicity. Therefore, when using reversed-phase high performance liquid chromatography (RP-HPLC) for purification, the full-length product containing the DMT group is more easily separated from the short-chain RNA that failed to be synthesized, thereby obtaining a purer RNA (see: Brian S. Sproat, RNA Synthesis Using 2'-O-(Tert-Butyldimethylsilyl) Protection, Oligonucleotide Synthesis, 2004, 288: 17-31.). This method is also called DMT ON purification, which can play a good separation role in HPLC.
[0004] Currently, there are two main methods for post-treatment of RNA: a one-pot method and a step-by-step method. In the one-pot method (see: CA2593583A1 and CN101289486A), a methylamine aqueous solution is usually used to perform an aminolysis reaction on the synthesized RNA. After filtering through a filter, DMSO and triethylamine trihydrofluoride are directly added to the reaction solution to perform a TBDMS removal reaction to obtain the final product. The advantage of this method is that the first step of aminolysis and the second step of TBDMS removal are reacted together, thereby saving steps such as draining reagents and is easy to operate. However, in the one-pot method, the DMT group of the RNA will be removed, affecting the purification of the RNA. In addition, the RNA obtained by the one-pot method is usually more severely degraded than the step-by-step method.
[0005] In the step-by-step method, the first step of the aminolysis reaction is usually to deprotect the synthesized RNA under heating conditions using ammonia water, ammonia water / methylamine aqueous solution or ammonia water / methylamine ethanol solution, and then evaporate it to powder; the second step is the TBDMS removal reaction. For RNA purified based on DMT ON, the RNA powder after aminolysis is usually first dissolved with DMSO, and then a deprotecting agent is added to remove the TBDMS from the RNA under heating conditions, which can retain DMT; for RNA purified based on DMT OFF, the RNA powder after aminolysis is usually first dissolved with DMSO, and then triethylamine trihydrofluoride is added to remove the TBDMS from the RNA under heating conditions.
[0006] Currently, RNA purified based on DMT ON is usually post-processed using a step-by-step method. However, after the first step of aminolysis is completed, the aminolysis reagent of the first step needs to be drained before the second step can be carried out. The operation is cumbersome, costly, and time-consuming.
[0007] In summary, a RNA post-treatment method is provided, which can not only retain the advantages of the one-pot method for easy operation, but also retain the DMT group and avoid the problem of easy RNA degradation, which is of great significance in the field of RNA chemical synthesis. Summary of the invention
[0008] In view of the deficiencies in the prior art and actual needs, the present invention provides a post-treatment method for solid-phase synthesized RNA and its application. The post-treatment method is a one-pot method, which uses ammonia methanol solution for aminolysis, can effectively reduce the degradation of RNA during the aminolysis process, and improve the purity and yield of RNA. Through deprotection treatment, RNA retaining the DMT group can be obtained, which is conducive to purification using HPLC.
[0009] To achieve the above object, the present invention adopts the following technical solutions:
[0010] In a first aspect, the present invention provides a post-treatment method for solid phase synthesized RNA, the post-treatment method for solid phase synthesized RNA comprising:
[0011] The RNA obtained by solid phase synthesis is mixed with an aminolysis reagent for aminolysis treatment, and the RNA after aminolysis treatment is mixed with a deprotection reagent for deprotection treatment. The aminolysis reagent includes an ammonia methanol solution.
[0012] In the present invention, the ammonia methanol solution is used for aminolysis, which can effectively reduce the degradation of RNA during the aminolysis process, reduce degradation by-products, and improve the purity and yield of RNA.
[0013] Preferably, the concentration of ammonia in the ammonia methanol solution is 2 to 7 mol / L, including but not limited to 3 mol / L, 4 mol / L, 5 mol / L or 6 mol / L.
[0014] Preferably, the deprotection reagent comprises N-methylpyrrolidone, triethylamine and triethylamine trihydrofluoride.
[0015] In the present invention, N-methylpyrrolidone, triethylamine and triethylamine trihydrofluoride are compounded to obtain a deprotection reagent, which can effectively remove the tert-butyldimethoxysilyl (TBDMS) group protecting the 2'-hydroxyl group on RNA, but does not affect the dimethoxytrityl (DMT) group protecting the 5'-hydroxyl group, and quickly obtains RNA retaining the DMT group, which is helpful for efficient separation using high performance liquid chromatography.
[0016] The post-treatment method of the solid phase synthesized RNA in the present invention is a one-pot method, that is, after the RNA synthesized in the solid phase is subjected to an aminolysis reaction, a TBDMS removal reaction can be directly performed. The process is simple, the cycle is short and the cost is low. RNA with the DMT group retained can be obtained, which is convenient for purifying the RNA using HPLC. At the same time, the degradation of RNA can be effectively reduced.
[0017] Preferably, the volume ratio of N-methylpyrrolidone, triethylamine and triethylamine trihydrofluoride in the deprotection reagent is 6:(3-16):(4-20), including but not limited to 6:5:10, 6:10:9, 6:15:5, 6:4:6, 6:13:19, 6:12:18, 6:7:8, 6:8:9, 6:4:17, 6:9:16, 6:4:14, 6:7:13, 6:6:12, 6:5:7 or 6:14:11.
[0018] Preferably, the solid phase synthesis operation step comprises synthesizing RNA in an RNA synthesizer using a solid phase synthesis column and four phosphoramidite monomers A, U, C, and G.
[0019] Preferably, the time of the ammonolysis treatment is 1 to 2 h, including but not limited to 1.2 h, 1.3 h, 1.5 h, 1.6 h, 1.8 or 1.9 h, and the temperature of the ammonolysis treatment is 80 to 100 ° C, including but not limited to 81 ° C, 82 ° C, 83 ° C, 85 ° C, 90 ° C, 92 ° C, 94 ° C, 95 ° C, 96 ° C, 98 ° C or 99 ° C.
[0020] Preferably, the temperature of the deprotection treatment is 60-70°C, including but not limited to 62°C, 63°C, 64°C, 65°C, 66°C, 68°C or 69°C, and the time of the deprotection treatment is 15-45min, including but not limited to 16min, 17min, 18min, 19min, 20min, 25min, 30min, 32min, 35min, 38min, 40min, 42min, 43min or 44min.
[0021] Preferably, the ammonolysis treatment further includes a cooling step.
[0022] Preferably, the cooling comprises placing the RNA after aminolysis treatment at 0-4°C (eg, 1°C, 2°C or 3°C) for 3-6 minutes (eg, 4 minutes or 5 minutes).
[0023] Preferably, the deprotection treatment further includes a precipitation treatment step.
[0024] Preferably, the precipitation treatment comprises adding sodium chloride solution and ethanol to the RNA after deprotection treatment to obtain a mixed solution, allowing the mixed solution to stand, and then centrifuging and collecting the precipitate.
[0025] Preferably, the concentration of the sodium chloride solution is 2-7 mol / L, including but not limited to 3 mol / L, 4 mol / L, 5 mol / L or 6 mol / L.
[0026] Preferably, the standing temperature is -22 to -18°C, including but not limited to -21°C, -20°C or -19°C, and the standing time is 2 to 3h, including but not limited to 2.2h, 2.3h, 2.5h, 2.6h, 2.8 or 2.9h.
[0027] Preferably, the centrifugation time is 2 to 5 min, including but not limited to 2.2 min, 2.4 min, 2.6 min, 2.8 min, 3 min, 3.5 min, 4 min, 4.2 min, 4.5 min, 4.6 min or 4.8 min, and the centrifugation speed is 11000 to 14000 rpm, including but not limited to 11200 rpm, 11500 rpm, 12000 rpm, 13000 rpm, 13200 rpm, 13500 rpm, 13600 rpm or 13800 rpm.
[0028] As a preferred technical solution, the post-treatment method of the solid phase synthetic RNA comprises the following steps:
[0029] (1) Mixing the RNA obtained by solid phase synthesis with an aminolysis reagent and performing aminolysis at 80-100°C for 1-2 hours;
[0030] (2) Cooling the RNA after aminolysis at 0-4°C for 3-6 minutes;
[0031] (3) mixing the cooled RNA with a deprotection reagent and subjecting the RNA to a deprotection treatment at 60 to 70° C. for 15 to 45 minutes;
[0032] (4) Cooling the deprotected RNA at 0 to 4°C for 3 to 6 minutes, then adding sodium chloride solution and ethanol to obtain a mixed solution, allowing the mixed solution to stand at -22 to -18°C for 2 to 3 hours, then centrifuging at 11,000 to 14,000 rpm for 2 to 5 minutes and collecting the precipitate.
[0033] In a second aspect, the present invention provides a method for preparing RNA, the method for preparing RNA comprising:
[0034] RNA is synthesized in an RNA synthesizer using a solid phase synthesis column and four phosphoramidite monomers A, U, C, and G. The synthesized RNA is post-treated using the post-treatment method for solid phase RNA synthesis described in the first aspect, and the post-treated RNA is purified.
[0035] Compared with the prior art, the present invention has the following beneficial effects:
[0036] (1) In the post-treatment method of the solid phase RNA synthesis of the present invention, the use of ammonia methanol solution for aminolysis can effectively reduce the degradation of RNA during the aminolysis process, reduce degradation byproducts, and improve the purity and yield of RNA;
[0037] (2) In the post-treatment method of the solid phase RNA synthesis of the present invention, N-methylpyrrolidone, triethylamine and triethylamine trihydrofluoride are compounded to obtain a deprotection reagent, which can effectively remove the tert-butyldimethoxysilyl group on the RNA and retain the dimethoxytrityl group;
[0038] (3) The post-treatment method of the solid phase synthesized RNA of the present invention is a one-pot method, which has a simple process, a short cycle and low cost. It can obtain RNA that retains the DMT group, which is convenient for purifying the RNA using HPLC. At the same time, it can effectively reduce the degradation of RNA, thus solving the problems that the traditional one-pot post-treatment cannot retain the DMT group and the RNA is easily degraded, and the step-by-step post-treatment operation is cumbersome, time-consuming and costly. BRIEF DESCRIPTION OF THE DRAWINGS
[0039] Figure 1 This is a liquid chromatogram of the crude RNA product in Example 1 of the present invention;
[0040] Figure 2 This is the electrospray mass spectrometer of the main peak of the crude RNA product in Example 1 of the present invention;
[0041] Figure 3 This is a liquid chromatogram of the crude RNA product in Example 2 of the present invention;
[0042] Figure 4 This is a liquid chromatogram of a HPLC purification of RNA in Example 2 of the present invention;
[0043] Figure 5 This is a liquid chromatogram of secondary HPLC purification of RNA in Example 2 of the present invention;
[0044] Figure 6 This is the electrospray mass spectrometer of the secondary HPLC purified RNA in Example 2 of the present invention;
[0045] Figure 7 This is a liquid chromatogram of the crude RNA product in Example 3 of the present invention;
[0046] Figure 8 This is the electrospray mass spectrometer of the main peak of the crude RNA product in Example 3 of the present invention;
[0047] Fig. 9 This is a liquid chromatogram of the crude RNA product in Example 4 of the present invention;
[0048] Fig.10 This is the electrospray mass spectrometer of the main peak of the crude RNA product in Example 4 of the present invention;
[0049] Fig.11 This is a liquid chromatogram of the crude RNA product in Example 5 of the present invention;
[0050] Fig.12 This is the electrospray mass spectrometer of the main peak of the crude RNA product in Example 5 of the present invention;
[0051] Fig.13 This is a liquid chromatogram of the crude RNA product in Comparative Example 1 of the present invention;
[0052] Fig.14 This is a liquid chromatogram of the crude RNA product in Comparative Example 2 of the present invention;
[0053] Fig.15 It is the liquid chromatogram of the crude RNA product in Comparative Example 3 of the present invention. DETAILED DESCRIPTION
[0054] To further illustrate the technical means and effects of the present invention, the present invention is further described below in conjunction with the embodiments and drawings. It should be understood that the specific implementation methods described herein are only used to explain the present invention, rather than to limit the present invention.
[0055] If no specific techniques or conditions are specified in the examples, the techniques or conditions described in the literature in the field or the product instructions are used. If no manufacturer is specified for the reagents or instruments used, they are all conventional products that can be purchased through regular channels.
[0056] Example 1
[0057] In this example, an RNA sequence with a length of 17 ribonucleotides is synthesized on a 200 nmol synthesis column and detected by liquid chromatography-mass spectrometry. The sequence of the RNA is ACCGAGUCGGUGCUUUU (molecular weight: 5683.43). The solid phase synthesized RNA is post-treated by the solid phase synthesis RNA post-treatment method of the present invention. The specific steps are as follows:
[0058] (1) Oligonucleotide synthesis
[0059] The corresponding oligonucleotide sequence was synthesized on a Lingkun LK-48E synthesizer using a 200 nmol synthesis column, 0.25 mol / L 5-ethylthiotetrazolyl (ETT) in acetonitrile as an activating agent, 3% trichloroacetic acid in dichloromethane as a deprotecting agent, 10% acetic anhydride / acetonitrile and N-methylimidazole:pyridine:acetonitrile (volume ratio of 14:10:76) as capping agents, and 0.05 mol / L iodine in tetrahydrofuran:pyridine:water (volume ratio of 70:20:10) as an oxidant;
[0060] (2) Aminolysis
[0061] 1) After the synthesis is completed, the synthesis column is transferred to a 2 mL centrifuge tube, 200 μL of ammonia methanol solution (7 mol / L) is added, and aminolysis is carried out in a 90 °C water bath for 1.5 h;
[0062] 2) After the aminolysis is completed, take out the centrifuge tube and cool it in a 4°C refrigerator for 5 minutes;
[0063] 3) Transfer the supernatant to a centrifuge tube with a filter membrane, wash the synthesis column twice with 150 μL of anhydrous methanol, transfer the washing methanol to a centrifuge tube with a filter membrane, and centrifuge at 13200 rpm for 1 min;
[0064] (3) Removal of TBDMS protection
[0065] 1) Add 125 μL of a deprotection reagent of N-methylpyrrolidone / triethylamine / triethylamine trihydrofluoride (volume ratio of 6:3:4) to the solution after aminolysis treatment, shake gently, and remove TBDMS protection in a 65°C water bath for 30 min;
[0066] 2) After the TBDMS removal reaction is completed, take out the centrifuge tube and cool it in a 4°C refrigerator for 5 minutes;
[0067] 3) Add 20 μL of 5 mol / L NaCl aqueous solution and 1.4 mL of ethanol to the centrifuge tube and place in a -20°C refrigerator for 2.5 h;
[0068] 4) Take out the centrifuge tube, centrifuge at 13200 rpm for 3 min, discard the supernatant, and obtain RNA retaining the DMT group;
[0069] 5) Transfer the precipitate to a centrifugal dryer and dry under vacuum at 25°C for 10 min;
[0070] 6) Dissolve the precipitate in 400 μL of RNase-free water, shake thoroughly to dissolve, then transfer to a centrifuge tube with a filter membrane and centrifuge at 13200 rpm for 1 min;
[0071] 7) The obtained solution is subjected to liquid chromatography-mass spectrometry for detection. The liquid chromatography detection result is as follows: Figure 1 As shown, the results show that DMT is successfully retained on the target RNA, and the electrospray ionization mass spectrometry (ESI-MS) results of the main peak are as follows Figure 2 As shown, the results show that the molecular weight is the molecular weight of the target RNA (containing the DMT group), and the HPLC purity and molecular weight results are shown in Table 1.
[0072] Example 2
[0073] In this example, an RNA sequence with a length of 100 ribonucleotides is synthesized on a 200 nmol synthesis column and detected by liquid chromatography-mass spectrometry. The sequence of the RNA is UGACUGUGUGGUACCCUCUCGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCAACUUGAAAAAGUGGCACCGAGUCGGUGCUUUU (molecular weight: 32120.2). The solid phase synthesized RNA is post-treated by the post-treatment method for solid phase synthesis RNA of the present invention, and the specific steps are as follows:
[0074] (1) Oligonucleotide synthesis
[0075] The corresponding oligonucleotide sequence was synthesized on a Lingkun LK-48E synthesizer using a 200 nmol synthesis column, 0.25 mol / L 5-ethylthiotetrazolyl (ETT) in acetonitrile as an activating agent, 3% trichloroacetic acid in dichloromethane as a deprotecting agent, 10% acetic anhydride / acetonitrile and N-methylimidazole:pyridine:acetonitrile (volume ratio of 14:10:76) as capping agents, and 0.05 mol / L iodine in tetrahydrofuran:pyridine:water (volume ratio of 70:20:10) as an oxidant;
[0076] (2) Aminolysis
[0077] 1) After the synthesis is completed, the synthesis column is transferred to a 2 mL centrifuge tube, 200 μL of ammonia methanol solution (7 mol / L) is added, and aminolysis is performed in a water bath at 80 °C for 2 h;
[0078] 2) After the aminolysis is completed, take out the centrifuge tube and cool it in a 0℃ refrigerator for 3 minutes;
[0079] 3) Transfer the supernatant to a centrifuge tube with a filter membrane, wash the synthesis column twice with 150 μL of anhydrous methanol, transfer the washing methanol to a centrifuge tube with a filter membrane, and centrifuge at 13200 rpm for 1 min;
[0080] (3) Removal of TBDMS protection
[0081] 1) Add 125 μL of a deprotection reagent of N-methylpyrrolidone / triethylamine / triethylamine trihydrofluoride (volume ratio of 6:3:20) to the solution after aminolysis treatment, shake gently, and remove TBDMS protection in a 60°C water bath for 45 min;
[0082] 2) After the TBDMS removal reaction is completed, take out the centrifuge tube and cool it in a 0°C refrigerator for 3 minutes;
[0083] 3) Add 20 μL of 2 mol / L NaCl aqueous solution and 1.4 mL of ethanol to the centrifuge tube and place in a -18°C refrigerator for 3 h;
[0084] 4) Take out the centrifuge tube, centrifuge at 11000 rpm for 5 min, discard the supernatant, and obtain RNA retaining the DMT group;
[0085] 5) Transfer the precipitate to a centrifugal dryer and dry under vacuum at 25°C for 10 min;
[0086] 6) Dissolve the precipitate in 400 μL of RNase-free water, shake thoroughly to dissolve, then transfer to a centrifuge tube with a filter membrane and centrifuge at 13200 rpm for 1 min;
[0087] 7) The obtained solution is subjected to liquid chromatography-mass spectrometry for detection. The liquid chromatography detection result is as follows: Figure 3 As shown, the results showed that DMT was successfully retained on the target RNA;
[0088] 8) The obtained crude product was purified by HPLC, and the purified sample was tested by liquid chromatography-mass spectrometry. The liquid chromatography test results were as follows: Figure 4 As shown;
[0089] 9) The solution purified by HPLC was centrifuged under vacuum at 65°C for 1 h to obtain a white solid;
[0090] 10) Add the above white solid to 40 μL of 3% acetic acid aqueous solution and leave at room temperature for 45 min;
[0091] 11) Add 250 μL of Tris-HCl solution with pH=7.5 to the above acetic acid solution, shake thoroughly, and subject the resulting solution to HPLC for secondary purification. The purified sample is tested by liquid chromatography-mass spectrometry. The liquid chromatography test results are as follows: Figure 5 As shown, the ESI-MS results of the main peak are as follows Figure 6 As shown, the results show that the molecular weight is the molecular weight of the target RNA, and the HPLC purity and molecular weight results are shown in Table 1.
[0092] Example 3
[0093] In this example, an RNA sequence with a length of 17 ribonucleotides is synthesized on a 200 nmol synthesis column and detected by liquid chromatography-mass spectrometry. The sequence of the RNA is ACCGAGUCGGUGCUUUU (molecular weight: 5683.43). The solid phase synthesized RNA is post-treated by the solid phase synthesis RNA post-treatment method of the present invention. The specific steps are as follows:
[0094] (1) Oligonucleotide synthesis
[0095] The corresponding oligonucleotide sequence was synthesized on a Lingkun LK-48E synthesizer using a 200 nmol synthesis column, 0.25 mol / L 5-ethylthiotetrazolyl (ETT) in acetonitrile as an activating agent, 3% trichloroacetic acid in dichloromethane as a deprotecting agent, 10% acetic anhydride / acetonitrile and N-methylimidazole:pyridine:acetonitrile (volume ratio of 14:10:76) as capping agents, and 0.05 mol / L iodine in tetrahydrofuran:pyridine:water (volume ratio of 70:20:10) as an oxidant;
[0096] (2) Aminolysis
[0097] 1) After the synthesis is completed, the synthesis column is transferred to a 2 mL centrifuge tube, 200 μL of ammonia methanol solution (7 mol / L) is added, and the mixture is subjected to ammonolysis in a 100 °C water bath for 1 h;
[0098] 2) After the aminolysis is completed, take out the centrifuge tube and cool it in a 4°C refrigerator for 3 minutes;
[0099] 3) The supernatant was transferred to a centrifuge tube with a filter membrane, and the synthetic column was washed twice with 150 μL of anhydrous methanol. The washed methanol was also transferred to a centrifuge tube with a filter membrane, and centrifuged at 14,000 rpm for 1 min;
[0100] (3) Removal of TBDMS protection
[0101] 1) Add 125 μL of a deprotection reagent of N-methylpyrrolidone / triethylamine / triethylamine trihydrofluoride (volume ratio of 6:16:10) to the solution after aminolysis treatment, shake gently, and remove TBDMS protection in a 65°C water bath for 30 min;
[0102] 2) After the TBDMS removal reaction is completed, take out the centrifuge tube and cool it in a 4°C refrigerator for 5 minutes;
[0103] 3) Add 20 μL of 7 mol / L NaCl aqueous solution and 1.4 mL of ethanol to the centrifuge tube and place in a -22°C refrigerator for 2 h;
[0104] 4) Take out the centrifuge tube, centrifuge at 14000 rpm for 2 min, discard the supernatant, and obtain RNA retaining the DMT group;
[0105] 5) Transfer the precipitate to a centrifugal dryer and dry under vacuum at 25°C for 10 min;
[0106] 6) Dissolve the precipitate in 400 μL of RNase-free water, shake thoroughly to dissolve, then transfer to a centrifuge tube with a filter membrane and centrifuge at 13200 rpm for 1 min;
[0107] 7) The obtained solution is subjected to liquid chromatography-mass spectrometry for detection. The liquid chromatography detection result is as follows: Figure 7 As shown, the results show that DMT is successfully retained on the target RNA, and the electrospray ionization mass spectrometry (ESI-MS) results of the main peak are as follows Figure 8 As shown, the results show that the molecular weight is the molecular weight of the target RNA (containing the DMT group), and the purity and molecular weight results are shown in Table 1.
[0108] Example 4
[0109] In this example, an RNA sequence with a length of 17 ribonucleotides is synthesized on a 200 nmol synthesis column and detected by liquid chromatography-mass spectrometry. The sequence of the RNA is ACCGAGUCGGUGCUUUU. The solid phase synthesized RNA is post-treated. The specific steps are compared with those in Example 1, except that an equal amount of triethylamine trihydrofluoride is used for deprotection treatment in step (3). The rest is the same as in Example 1.
[0110] The obtained solution was tested by liquid chromatography-mass spectrometry. The liquid chromatography test results were as follows: Fig. 9 As shown, the mass spectrum results of the main peak are as follows Fig.10 As shown, the results showed that DMT was not retained on the target RNA, and the purity and molecular weight results are shown in Table 1.
[0111] Example 5
[0112] In this example, an RNA sequence with a length of 17 ribonucleotides is synthesized on a 200 nmol synthesis column and detected by liquid chromatography-mass spectrometry. The sequence of the RNA is ACCGAGUCGGUGCUUUU. The solid-phase synthesized RNA is post-treated. The specific steps are the same as those in Example 1, except that step (2) uses a 2 mol / L ammonia methanol solution for aminolysis treatment. The rest is the same as in Example 1.
[0113] The obtained solution was tested by liquid chromatography-mass spectrometry. The liquid chromatography test results were as follows: Fig.11 As shown, the mass spectrum results of the main peak are as follows Fig.12 As shown, the results showed that DMT was retained on the target RNA, and the purity and molecular weight results are shown in Table 1.
[0114] Comparative Example 1
[0115] In this comparative example, an RNA sequence with a length of 17 ribonucleotides is synthesized on a 200 nmol synthesis column and detected by liquid chromatography-mass spectrometry. The sequence of the RNA is ACCGAGUCGGUGCUUUU. The solid phase synthesized RNA is post-treated by the solid phase synthesis RNA post-treatment method of the present invention. The specific steps are compared with those in Example 1, except that step (2) uses an equal amount of methylamine aqueous solution (30%) for aminolysis treatment, and the rest are the same as in Example 1.
[0116] The obtained solution was tested by liquid chromatography-mass spectrometry. The liquid chromatography test results were as follows: Fig.13 As shown, the results show that although DMT is successfully retained on the target RNA, there are more RNA degradation products with a retention time after the main peak of the target RNA. The purity results are shown in Table 1, which shows that compared with the use of ammonia methanol solution for aminolysis, the use of methylamine aqueous solution for aminolysis will cause RNA to be significantly degraded and produce more RNA degradation products, indicating that the present invention controls the use of ammonia methanol solution for aminolysis, can reduce RNA degradation, reduce degradation products, and significantly improve the purity and yield of RNA.
[0117] Comparative Example 2
[0118] In this comparative example, an RNA sequence with a length of 17 ribonucleotides is synthesized on a 200 nmol synthesis column and detected by liquid chromatography-mass spectrometry. The sequence of the RNA is ACCGAGUCGGUGCUUUU. The solid phase synthesized RNA is post-treated by the solid phase synthesis RNA post-treatment method of the present invention. The specific steps are compared with those in Example 1, except that step (2) uses an equal amount of aqueous ammonia solution (30%) for aminolysis treatment, and the rest are the same as in Example 1.
[0119] The obtained solution was tested by liquid chromatography-mass spectrometry. The liquid chromatography test results were as follows: Fig.14 As shown, the results show that although DMT is successfully retained on the target RNA, there are more RNA degradation products with a retention time after the main peak of the target RNA. The purity results are shown in Table 1, which shows that compared with the use of ammonia methanol solution for aminolysis, the use of ammonia aqueous solution for aminolysis will cause RNA to be significantly degraded and produce more RNA degradation products, indicating that the present invention controls the use of ammonia methanol solution for aminolysis, can reduce RNA degradation, reduce degradation products, and significantly improve the purity and yield of RNA.
[0120] Comparative Example 3
[0121] In this comparative example, an RNA sequence with a length of 17 ribonucleotides is synthesized on a 200 nmol synthesis column and detected by liquid chromatography-mass spectrometry. The sequence of the RNA is ACCGAGUCGGUGCUUUU. The solid phase synthesized RNA is post-treated by the solid phase synthesis RNA post-treatment method of the present invention. The specific steps are compared with those of Example 1, except that step (2) uses an equal amount of methylamine ethanol solution (30%) for aminolysis treatment, and the rest are the same as Example 1.
[0122] The obtained solution was tested by liquid chromatography-mass spectrometry. The liquid chromatography test results were as follows: Fig.15 As shown, the results show that although DMT is successfully retained on the target RNA, there are more RNA degradation products with a retention time after the main peak of the target RNA. The purity results are shown in Table 1, which shows that compared with the use of ammonia methanol solution for aminolysis, the use of methylamine ethanol solution for aminolysis will cause RNA to be significantly degraded and produce more RNA degradation products, indicating that the present invention controls the use of ammonia methanol solution for aminolysis, can reduce RNA degradation, reduce degradation products, and significantly improve the purity and yield of RNA.
[0123] Table 1
[0124] Experimental Group Retention time (min) HPLC purity (%) Molecular weight Example 1 3.67 65.21 5684.1 Example 2 2.97 99.47 32125.1 Example 3 3.68 58.28 5684.2 Example 4 2.27 62.98 5381.9 Example 5 3.65 54.21 5684.2 Comparative Example 1 3.61 6.37 5683.2 Comparative Example 2 3.66 22.60 5683.1 Comparative Example 3 3.62 45.63 5683.2
[0125] As can be seen from Table 1, by comparing the results of Example 1 with Comparative Examples 1, 2 and 3, the present invention controls the use of ammonia methanol solution for aminolysis, so that RNA degradation is less, thereby being able to obtain more and purer RNA; by comparing the results of Example 1 and Example 4, it can be seen that the present invention uses N-methylpyrrolidone, triethylamine and triethylamine trihydrofluoride as a deprotecting agent, and performs a one-pot post-treatment, which can effectively remove TBDMS and retain the DMT group, which is beneficial to the separation and purification of RNA; compared with the step-by-step method, the method of the present invention has simpler operating steps, so that the target RNA retaining the DMT group can be obtained faster, effectively shortening the time and saving costs.
[0126] In summary, the present invention adopts N-methylpyrrolidone, triethylamine and triethylamine trihydrofluoride as a deprotecting agent to perform a one-pot post-treatment on RNA, which can not only retain the DMT group, but also avoid the problem of cumbersome operation of the step-by-step method. At the same time, ammonia methanol solution is used for aminolysis, which can effectively reduce the degradation of RNA and significantly improve the purity and yield of RNA.
[0127] The applicant declares that the present invention illustrates the detailed method of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned detailed method, that is, it does not mean that the present invention must rely on the above-mentioned detailed method to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.
Claims
1. A post-treatment method for solid phase RNA synthesis, characterized in that: The post-treatment method of the solid phase synthetic RNA comprises: The RNA obtained by solid phase synthesis is mixed with an aminolysis reagent for aminolysis treatment, and the RNA after aminolysis treatment is mixed with a deprotection reagent for deprotection treatment; The ammonolysis reagent includes ammonia methanol solution; The concentration of ammonia in the ammonia methanol solution is 2-7 mol / L; The deprotection reagent includes N-methylpyrrolidone, triethylamine and triethylamine trihydrofluoride; The volume ratio of N-methylpyrrolidone, triethylamine and triethylamine trihydrofluoride in the deprotection reagent is 6:(3-16):(4-20); The time of the ammonolysis treatment is 1-2 h, and the temperature of the ammonolysis treatment is 80-100°C; The temperature of the deprotection treatment is 60-70° C., and the time of the deprotection treatment is 15-45 min; The step of cooling is also included after the ammonolysis treatment; The cooling includes placing the RNA after aminolysis treatment at 0-4°C for 3-6 minutes; The deprotection treatment further includes a precipitation treatment step; the precipitation treatment includes adding sodium chloride solution and ethanol to the RNA after the deprotection treatment to obtain a mixed solution, allowing the mixed solution to stand, and then centrifuging and collecting the precipitate.
2. The post-treatment method for solid phase RNA synthesis according to claim 1, characterized in that: The concentration of the sodium chloride solution is 2-7 mol / L.
3. The post-treatment method for solid phase RNA synthesis according to claim 1, characterized in that: The standing temperature is -22 to -18°C, and the standing time is 2 to 3 hours.
4. The post-treatment method for solid phase RNA synthesis according to claim 1, characterized in that: The centrifugal time is 2-5 min, and the centrifugal speed is 11000-14000 rpm.
5. A method for preparing RNA, characterized in that: The method for preparing RNA comprises: RNA is synthesized in an RNA synthesizer using a solid phase synthesis column and four phosphoramidite monomers A, U, C, and G, the synthesized RNA is post-treated using the solid phase RNA synthesis post-treatment method according to any one of claims 1 to 4, and the post-treated RNA is purified.
